246 related articles for article (PubMed ID: 4723818)
1. Drug-induced blood dyscrasias in Sweden.
Böttiger LE; Westerholm B
Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
Böttiger LE; Furhoff AK; Holmberg L
Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
[TBL] [Abstract][Full Text] [Related]
3. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
Wiholm BE; Emanuelsson S
Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
[TBL] [Abstract][Full Text] [Related]
4. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
Böttiger LE; Böttiger B
Acta Med Scand; 1981; 210(6):475-9. PubMed ID: 7331894
[TBL] [Abstract][Full Text] [Related]
5. [Drugs and blood].
Keiser G
Schweiz Rundsch Med Prax; 1985 Jan; 74(3):40-5. PubMed ID: 2857497
[No Abstract] [Full Text] [Related]
6. Aplastic anaemia. II. Drug-induced aplastic anaemia.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):319-21. PubMed ID: 5081069
[No Abstract] [Full Text] [Related]
7. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
Inman WH
Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
[TBL] [Abstract][Full Text] [Related]
8. Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases.
Polak BC; Wesseling H; Schut D; Herxheimer A; Meyler L
Acta Med Scand; 1972 Nov; 192(5):409-14. PubMed ID: 5083381
[No Abstract] [Full Text] [Related]
9. Immunologic drug-induced blood dyscrasias.
Miescher PA; Miescher A
Klin Wochenschr; 1978 Jan; 56(1):1-5. PubMed ID: 146758
[No Abstract] [Full Text] [Related]
10. Drug-induced blood dyscrasias.
Eisenhauer LA
Nurs Clin North Am; 1972 Dec; 7(4):799-808. PubMed ID: 4485732
[No Abstract] [Full Text] [Related]
11. Oxyphenbutazone (Tanderil) and blood dyscrasia.
Brownlie BE; Strang PJ
N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
[No Abstract] [Full Text] [Related]
12. Acquired haemolytic anaemia. I. Incidence and aetiology.
Böttiger LE; Westerholm B
Acta Med Scand; 1973 Mar; 193(3):223-6. PubMed ID: 4739592
[No Abstract] [Full Text] [Related]
13. Acquired haemolytic anaemia. II. Drug-induced haemolytic anaemia.
Böttiger LE; Westerholm B
Acta Med Scand; 1973 Mar; 193(3):227-31. PubMed ID: 4693788
[No Abstract] [Full Text] [Related]
14. [Drug induced hematologic changes].
Palva I
Duodecim; 1974; 90(20):1344-51. PubMed ID: 4139010
[No Abstract] [Full Text] [Related]
15. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
Levy M; Kelly JP; Kaufman DW; Shapiro S
Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
[TBL] [Abstract][Full Text] [Related]
16. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anaemia. I. Incidence and aetiology.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068
[No Abstract] [Full Text] [Related]
18. Drug-induced blood disorders.
Danielson DA; Douglas SW; Herzog P; Jick H; Porter JB
JAMA; 1984 Dec; 252(23):3257-60. PubMed ID: 6151006
[TBL] [Abstract][Full Text] [Related]
19. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
Rawson NS; Harding SR; Malcolm E; Lueck L
J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced hematological disorders].
Nishimura J; Motomura S; Akagi T
Nihon Rinsho; 2007 Oct; 65 Suppl 8():99-105. PubMed ID: 18074523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
